Insiders Cue Biopharma, Inc.

Equities

CUE

US22978P1066

Delayed Nasdaq Other stock markets 17:37:34 13/05/2024 BST			5-day change	1st Jan Change
1.685 ^USD	-3.16%		-18.99%	-36.17%

05-09	Cue Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-08	Transcript : Cue Biopharma, Inc., Q4 2023 Earnings Call, Apr 08, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cue Biopharma, Inc. Announces Resignation of Aaron Fletcher as Member of the Board of Directors, Effective October 9, 2023	14/09/23	CI
Cue Biopharma, Inc Appoints Pamela D. Garzone to Its Board of Directors	25/04/23	CI
Cue Biopharma, Inc. Announces Appointment of Patrick Verheyen to Its Board of Directors	12/04/23	CI
Ms. Howson Intends to Retire from the Board of Directors of Cue Biopharma, Inc	10/03/23	CI
Cue Biopharma, Inc. Announces the Appointment of Rafi Ahmed to its Scientific Advisory Board	16/02/23	CI
Cue Biopharma, Inc. Announces Executive Changes	23/01/23	CI
Cue Biopharma, Inc. Announces Resignation of Cameron Gray as Member of the Board of Directors and All Committees	22/06/22	CI
Insider Buy: Cue Biopharma	25/05/22	MT
Insider Buy: Cue Biopharma	04/04/22	MT
Cue Biopharma Inc. Announces Appointment of Patricia Nasshorn as Chief Business Officer	15/12/21	CI
Insider Sell: Cue Biopharma	17/11/21	MT
Insider Sell: Cue Biopharma	27/09/21	MT
Cue Biopharma, Inc. Announces Executive Changes	25/02/21	CI
Cue Biopharma, Inc. Appoints Dr. Matteo Levisetti as Senior Vice President of Clinical Development, Effective February 22, 2021	17/02/21	CI
Cue Biopharma, Inc. Announces Appointment of Tamar Howson to Board of Directors	17/09/20	CI
Cue Biopharma, Inc. Appoints Kerri-Ann Millar as Chief Financial Officer	24/08/20	CI
Cue Biopharma, Inc. Announces Board Resignations	10/02/20	CI
Cue Biopharma, Inc. Appoints Aaron Fletcher to Serve as A Member of the Board of Directors of the Company	09/10/19	CI
Cue Biopharma, Inc. Announces Executive Changes	07/10/19	CI
Cue Biopharma, Inc. Appoints Randall R. Rader to Serve as the Chair of Intellectual Property Committee	03/10/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Cue Biopharma, Inc.

Equities

CUE

US22978P1066

Insiders

Filters